Cargando…
The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines
Although gastrointestinal stromal tumors (GISTs) are a rare type of cancer, they are the commonest sarcoma in the gastrointestinal tract. Molecularly targeted therapy, such as imatinib therapy, has revolutionized the treatment of advanced GIST and facilitates scientific research on GIST. Nevertheles...
Autores principales: | Nishida, Toshirou, Blay, Jean-Yves, Hirota, Seiichi, Kitagawa, Yuko, Kang, Yoon-Koo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688306/ https://www.ncbi.nlm.nih.gov/pubmed/26276366 http://dx.doi.org/10.1007/s10120-015-0526-8 |
Ejemplares similares
-
Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world
por: Nishida, Toshirou, et al.
Publicado: (2019) -
Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I
por: Nishida, Toshirou, et al.
Publicado: (2015) -
Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor
por: Koo, Dong-Hoe, et al.
Publicado: (2016) -
Impact of the KIT/PDGFRA genotype on prognosis in imatinib‐naïve Japanese patients with gastrointestinal stromal tumor
por: Cho, Haruhiko, et al.
Publicado: (2021) -
The Role of Endoscopy in the Diagnosis of Gastric Gastrointestinal Stromal Tumors
por: Nishida, Toshirou
Publicado: (2015)